Scott Tarriff, President and CEO at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 39,560 shares at $63.52 ($2.5M) on 2016-03-01, disclosed to the SEC on 2016-03-03.
Open-market sale of $2.5M EGRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.70 | 7,802 | $489K | 19.6% |
| 2 | $62.70 | 7,802 | $489K | 19.6% |
| 3 | $63.52 | 11,978 | $761K | 30.4% |
| 4 | $63.52 | 11,978 | $761K | 30.4% |
| Total | $63.20 avg | 39,560 | $2.5M | 100% |
| Filing → |
| EGRX | SELL | 2023-05-18 | $300K | — | Filing → |
| EGRX | SELL | 2023-05-15 | $1.2M | — | Filing → |
| EGRX | SELL | 2019-04-03 | $2.5M | — | Filing → |